Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications
…, JA SCHALKEN, FM DEBRUYNE… - The Journal of …, 1996 - Wiley Online Library
In order to understand the clinical and biological implications of prostate cancer multifocality
and heterogeneity, we investigated their occurrence in relation to variables such as tumour …
and heterogeneity, we investigated their occurrence in relation to variables such as tumour …
Controlled trial of pelvic floor exercises in the treatment of urinary stress incontinence in general practice.
TL Lagro-Janssen, FM Debruyne, AJ Smits… - British Journal of …, 1991 - bjgp.org
The aim of this study was to assess the usefulness of pelvic floor exercises in the treatment
of urinary incontinence in women and to analyse the factors which determine a successful …
of urinary incontinence in women and to analyse the factors which determine a successful …
fur gene expression as a discriminating marker for small cell and nonsmall cell lung carcinomas.
…, SS Wagenaar, FM Debruyne… - The Journal of …, 1987 - Am Soc Clin Investig
The recently discovered fur gene encodes a membrane-associated protein with a recognition
function. To further characterize the gene, we studied its expression by Northern blot …
function. To further characterize the gene, we studied its expression by Northern blot …
The role of nocturia in the quality of life of men with lower urinary tract symptoms
MM Van Dijk, H Wijkstra, FM Debruyne… - BJU …, 2010 - Wiley Online Library
Study Type – Symptom prevalence (retrospective cohort) Level of Evidence 2b OBJECTIVES
To determine the role of treatment‐associated improvement in nocturia in health‐related …
To determine the role of treatment‐associated improvement in nocturia in health‐related …
Role of testosterone in managing advanced prostate cancer
KO Rove, FM Debruyne, B Djavan, LG Gomella… - Urology, 2012 - Elsevier
Androgen deprivation therapy is frequently used to treat patients with advanced prostate
cancer. New therapies for metastatic castration-resistant prostate cancer have drawn increased …
cancer. New therapies for metastatic castration-resistant prostate cancer have drawn increased …
Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co …
…, NP Koper, AL Verbeek, FM Debruyne - British journal of …, 1994 - europepmc.org
Objective To evaluate whether it is worthwhile to implement routine random biopsies from
the normal-looking urothelium in the management of patients with primary superficial …
the normal-looking urothelium in the management of patients with primary superficial …
Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen
…, H Wijkstra, CA van de Kaa, FM Debruyne… - Prostate cancer and …, 2001 - nature.com
A system for computerised analysis of ultrasonographic prostate images (AUDEX= Automated
Urologic Diagnostic EXpert system) for the detection of prostate carcinoma was developed…
Urologic Diagnostic EXpert system) for the detection of prostate carcinoma was developed…
Rapid microwave‐stimulated fixation of entire prostatectomy specimens
…, JA Schalken, FM Debruyne… - The Journal of …, 1997 - Wiley Online Library
Conventional fixation of large solid surgical specimens is a slow process. Consequently,
autolytic damage to tissues may occur if the fixative does not reach the central part of the …
autolytic damage to tissues may occur if the fixative does not reach the central part of the …
A retrospective study of high mobility group protein I (Y) as progression marker for prostate cancer determined by in situ hybridization
…, HG van der Poel, HFM Karthaus, FM Debruyne… - British journal of …, 1996 - nature.com
In a previous study using RNA in situ hybridisation (RISH), we found a significant correlation
between high mobility group protein I/Y,[HMG-I (Y)] mRNA expression and tumour stage …
between high mobility group protein I/Y,[HMG-I (Y)] mRNA expression and tumour stage …
Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma.
…, JO Wakka, A van Bokhoven, FM Debruyne… - Clinical cancer research …, 1998 - AACR
In many carcinomas, E-cadherin is considered to be a prognostic marker for patient survivals,
and its decreased expression is associated with metastatic disease. Among renal cell …
and its decreased expression is associated with metastatic disease. Among renal cell …